Edmond de Rothschild Holding’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,000
| Closed | -$35.1K | – | 668 |
|
|
2023
Q4 | $35.1K | Hold |
13,000
| – | – | ﹤0.01% | 590 |
|
|
2023
Q3 | $20.5K | Hold |
13,000
| – | – | ﹤0.01% | 623 |
|
|
2023
Q2 | $34.2K | Hold |
13,000
| – | – | ﹤0.01% | 606 |
|
|
2023
Q1 | $47.3K | Hold |
13,000
| – | – | ﹤0.01% | 592 |
|
|
2022
Q4 | $50.7K | Hold |
13,000
| – | – | ﹤0.01% | 636 |
|
|
2022
Q3 | $55K | Hold |
13,000
| – | – | ﹤0.01% | 645 |
|
|
2022
Q2 | $59K | Hold |
13,000
| – | – | ﹤0.01% | 648 |
|
|
2022
Q1 | $73K | Hold |
13,000
| – | – | ﹤0.01% | 624 |
|
|
2021
Q4 | $81K | Hold |
13,000
| – | – | ﹤0.01% | 650 |
|
|
2021
Q3 | $128K | Hold |
13,000
| – | – | ﹤0.01% | 597 |
|
|
2021
Q2 | $116K | Hold |
13,000
| – | – | ﹤0.01% | 591 |
|
|
2021
Q1 | $144K | Buy |
+13,000
| New | +$144K | ﹤0.01% | 516 |
|